A new promising cancer treatment, aiming to inhibit tumor growth by attacking the signaling pathway of transforming growth factor beta (TGFbeta) has just left the SciLifeLab Drug Discovery and Development … Continue reading Latest DDD-exit: Promising antibody candidate in the fight against cancer